- SIRIO joined four named omega-3 suppliers in a long-term sourcing, quality and industrial collaboration.
- The CDMO will test incoming batches for purity, oxidation, heavy metals, plasticizers and mineral oil aromatics.
SIRIO Pharma Co., a Shantou, China-based nutraceutical CDMO listed on the Shenzhen Stock Exchange, said Nov. 12 that it formed an omega-3 supply alliance with KD Nutra, Epax, Golden Omega and Fermentalg. The participants agreed to long-term cooperation covering diversified sourcing, quality management and industrial collaboration.
SIRIO said the named suppliers span high-purity omega-3 processing, concentrated fish oil, vertically integrated Chilean marine oils and fermentation-derived DHA. Staggered fishing seasons in the Northern and Southern hemispheres are intended to reduce dependence on a single harvest cycle, while algal oil adds a non-marine production route.
The CDMO said its omega-3 identification laboratory records purity, oxidation values, heavy metals, plasticizers and mineral oil aromatic hydrocarbons for every batch. Qualified inputs can then move through formulation development and commercial manufacturing across SIRIO’s softgel, gummy and beverage operations.
Independent Nutrition Insight reporting in September described tightening fish-oil availability after disruption to Peru’s anchoveta fishery, with industry speakers pointing to algae and other sources as complementary supplies. SIRIO has five R&D centers and seven production bases, but the company did not disclose purchase commitments, volumes, exclusivity or pricing for the new alliance.
Jack Zhou, SIRIO’s head of global strategic procurement, said the alliance should conserve raw inputs and reduce loss.
“The alliance was founded not on taking, but on cherishing.”
Jack Zhou, head of global strategic procurement, SIRIO





